Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Issuer Symbol
-
CGON on Nasdaq
There are no Buy or Sell transactions made by Decheng Capital Global Life Sciences Fund IV, L.P. since 11 Mar 2025
Holdings reported by Decheng Capital Global Life Sciences Fund IV, L.P. for CG Oncology, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
4,958,810 |
$175,343,522 |
$35.36 |
29 Jan 2024 |
Direct |
|
|
| Series C Preferred Stock |
0 |
|
|
29 Jan 2024 |
Direct |
Common Stock |
|
| Series E Preferred Stock |
0 |
|
|
29 Jan 2024 |
Direct |
Common Stock |
|
| Series F Preferred Stock |
0 |
|
|
29 Jan 2024 |
Direct |
Common Stock |
|
Transactions reported by Decheng Capital Global Life Sciences Fund IV, L.P. for CG Oncology, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.